Movano Inc. (MOVE), headquartered in Pleasanton, California, is a health-focused technology company dedicated to leveraging technology to transform personal health. Established in 2018, the company develops non-invasive wearable devices that continuously measure critical health parameters previously only available intermittently or in clinical settings. By doing so, the company is aiming to make it easier for consumers to take control of their health and wellness.
One of Movano's primary differentiators is its Radio Frequency (RF), glucose-monitoring technology, which aims to aid people with diabetes in managing their condition more effectively by providing real-time glucose level monitoring. Consequently, this technological advance is designed to empower users to make more informed decisions about their diet, activity, and medication in order to manage blood glucose levels. Thus, it has the potential to dramatically improve the lives of millions of people affected by diabetes and other chronic health conditions worldwide.
Beyond this, Movano Inc. also focuses on addressing high blood pressure and obesity issues alongside diabetes. The company is tapping technology to develop a broad range of smart wearable devices to monitor key health parameters like blood pressure, heart rate, oxygen levels, body temperature, and more. These devices can help users understand and manage their wellness while providing valuable data to their healthcare providers.
Movano Inc. operates with a professed mission to empower individuals, providers and research institutions with products and tools that promote better health. The company envisions a future where preventing, managing, and treating chronic diseases is not done intermittently, but is instead woven into the fabric of everyday life.
Transparency and accuracy are integral to the company’s ethos. Movano is focused on FDA approval for safety and effectiveness, and their technology is validated through rigorous clinical studies. The accessibility and affordability of their products are also at the forefront.
Movano Inc. (MOVE) is a common stock company that went public in early 2021. The success of the company and its ability to innovate are testament to the dynamic, experienced team of individuals leading the company’s operations. They combine expertise from the world of medicine, technology, and business to create a health-technology company positioning itself at the forefront of the chronically evolved health market. In summary, Movano Inc. is moving beyond conventional healthcare approaches to create a healthier future through the power of wearable technologies.